Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol MDI propellant crossover PK study
NL-OMON53462Completed
- Sponsor
- GSK
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of salbutamol in asthma (2 arms), sponsored by GSK. Primary endpoint: Pharmacokinetics of salbutamol. Started Apr 2023; status: completed.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NL-OMON53462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53462.